Cargando…

Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia

Detalles Bibliográficos
Autores principales:	Atakhanov, Salim, Christen, Deborah, Rolles, Benjamin, Schüler, Herdit M., Panse, Jens, Chatain, Nicolas, Koschmieder, Steffen, Brümmendorf, Tim H., Toledo, Marcelo A. S., Zenke, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486762/ https://www.ncbi.nlm.nih.gov/pubmed/36125543 http://dx.doi.org/10.1007/s00277-022-04975-9

Ejemplares similares

KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile
por: de Toledo, Marcelo A. S., et al.
Publicado: (2023)

Systemic Lymphadenopathic Mastocytosis with Eosinophilia
por: Im, Soyoung, et al.
Publicado: (2022)

CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes
por: Olschok, Kathrin, et al.
Publicado: (2021)

P1365: HUMAN CD117 AS AN IMMUNOTHERAPEUTIC TARGET IN PRECLINICAL MODELS OF ADVANCED SYSTEMIC MASTOCYTOSIS
por: Kaiser, Anne, et al.
Publicado: (2023)

P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
por: Olschok, Kathrin, et al.
Publicado: (2023)

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
por: Olschok, Kathrin, et al.
Publicado: (2023)

Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem Cells
por: Satoh, Taiki, et al.
Publicado: (2021)

Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion
por: Han, Lijuan, et al.
Publicado: (2016)

Inflammation and anti-inflammatory approaches in myeloproliferative neoplasm
por: Koschmieder, Steffen, et al.
Publicado: (2018)

Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing
por: Kirschner, Martin M. J., et al.
Publicado: (2015)

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
por: Vieri, Margherita, et al.
Publicado: (2023)

Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita
por: Vieri, Margherita, et al.
Publicado: (2020)

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients
por: Schubert, Claudia, et al.
Publicado: (2017)

Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms
por: Chatain, Nicolas, et al.
Publicado: (2020)

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms
por: Vieri, Margherita, et al.
Publicado: (2023)

P804: EX VIVO TREATMENT WITH ELTROMBOPAG RESCUES HEMATOPOIETIC STEM CELLS FROM ANTI-THYMOCYTE GLOBULIN-RELATED DAMAGE DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH APLASTIC ANEMIA
por: Vieri, M., et al.
Publicado: (2022)

P1004: ACTIVATING MUTATIONS IN JAK2 AND CALR DIFFERENTIALLY AFFECT INTRACELLULAR CALCIUM LEVELS AND CALCIUM FLUX
por: Bhuria, Vikas, et al.
Publicado: (2023)

Early and late stage MPN patients show distinct gene expression profiles in CD34(+) cells
por: Baumeister, Julian, et al.
Publicado: (2021)

Beyond iPS!
Publicado: (2012)

Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia
por: Lasho, T L, et al.
Publicado: (2015)

Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha
por: Schubert, Claudia, et al.
Publicado: (2019)

Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms
por: Kalmer, Milena, et al.
Publicado: (2022)

Eosinophilia in a patient with aggressive systemic mastocytosis harboring a KIT D816V mutation: A case report
por: Cao, Lihong, et al.
Publicado: (2023)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
por: Baumeister, Julian, et al.
Publicado: (2021)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)

Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009)

Evolving science enhanced with iPS
Publicado: (2007)

iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016)

Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
por: Parting, Oliver, et al.
Publicado: (2020)

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

Perioperative intravenous immunoglobulin treatment in a patient with severe acquired von Willebrand syndrome: case report and review of the literature
por: Jennes, Eva, et al.
Publicado: (2017)

A 26-Year-Old Female with Systemic Mastocytosis with Associated Myeloid Neoplasm with Eosinophilia and Abnormalities of PDGFRB, t(4;5)(q21;q33)
por: Brown, Laura E., et al.
Publicado: (2016)

Induced pluripotent stem (iPS) cells: an up-to-the-minute review
por: Lau, Frank, et al.
Publicado: (2009)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

The tumourigenicity of iPS cells and their differentiated derivates
por: Liu, Zhiqiang, et al.
Publicado: (2013)

iPS-Cinderella Story in Cell Biology
Publicado: (2010)

Modeling Kidney Disease with iPS Cells
por: Freedman, Benjamin S.
Publicado: (2015)

Questions Surrounding iPS Cells in Japan
por: Yui, Yoshiki
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h17m26j0um8feu43snrdi8rojm